Data Disclosure
In accordance with the EFPIA Disclosure Code Bayer discloses transfers of value connected to the development and commercialization of prescription-only human pharmaceuticals to healthcare professionals and healthcare organizations.
The disclosed data include transfers of value in four main categories
| Categories | Transfer of value | |
Healthcare Professionals | Healthcare Organizations | |
| Donations and grants | - | Whether monetary or other |
| Events | 1. Registration fees 2. Travel & accommodation | 1. Sponsorship 2. Registration fees (if applicable) 3. Travel & accommodation |
| Service and consultancy | 1. Fees 2. Related expenses agreed in the contract (including, for example, travel, accommodation & registration fees) | |
| Research and development | Fees, travel & accommodation, and other related expenses that are covered in connection with the service | |
We at Bayer confirm that our disclosures of transfers of value (ToVs) to HCPs and HCOs have been reported in application of the EFPIA Disclosure Code key principles.
Learn More About our Disclosure Methodology
The general rules of the EFPIA Disclosure Code apply to all member companies and all companies will disclose transfers of value made to healthcare professionals and healthcare organizations in a pre-defined format. However, some details of the reporting methodology are left for the individual companies to decide in order to allow the necessary flexibility to adjust to the internal processes. This methodology note allows you to understand how Bayer is documenting and disclosing the relevant information.
 | ||||||||||
|
| |||||||||